DK1034174T3 - Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer - Google Patents

Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer

Info

Publication number
DK1034174T3
DK1034174T3 DK98952578T DK98952578T DK1034174T3 DK 1034174 T3 DK1034174 T3 DK 1034174T3 DK 98952578 T DK98952578 T DK 98952578T DK 98952578 T DK98952578 T DK 98952578T DK 1034174 T3 DK1034174 T3 DK 1034174T3
Authority
DK
Denmark
Prior art keywords
azaring
heterocyclic group
ach receptor
receptor modulators
ether derivatives
Prior art date
Application number
DK98952578T
Other languages
Danish (da)
English (en)
Inventor
Dan Peters
Gunnar M Olsen
Simon Feldbaek Nielsen
Elsebet Ostergaard Nielsen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK1034174T3 publication Critical patent/DK1034174T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98952578T 1997-11-05 1998-11-05 Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer DK1034174T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK125997 1997-11-05
DKPA199800850 1998-06-26
PCT/DK1998/000478 WO1999024422A1 (fr) 1997-11-05 1998-11-05 Derives d'azacyclo-ether et leur utilisation en tant que modulateurs des recepteurs ach nicotiniques

Publications (1)

Publication Number Publication Date
DK1034174T3 true DK1034174T3 (da) 2003-09-22

Family

ID=26064766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98952578T DK1034174T3 (da) 1997-11-05 1998-11-05 Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer

Country Status (11)

Country Link
US (3) US6756386B1 (fr)
EP (2) EP1034174B1 (fr)
JP (1) JP2001522846A (fr)
CN (1) CN1173972C (fr)
AT (1) ATE247104T1 (fr)
AU (1) AU747419B2 (fr)
CA (1) CA2306477A1 (fr)
DE (1) DE69817214T2 (fr)
DK (1) DK1034174T3 (fr)
NZ (1) NZ503626A (fr)
WO (1) WO1999024422A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2341989A1 (fr) * 1998-08-25 2000-03-02 Ortho-Mcneil Pharmaceutical, Inc. Pyridyl ethers et thioethers tenant lieu de ligands pour le recepteur de l'acetycholine nicotinique, et application therapeutique
US6303638B1 (en) 1999-08-06 2001-10-16 The Regents Of The University Of California Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor
CA2381252A1 (fr) * 1999-09-14 2001-03-22 Abbott Laboratories Composes d'ether 3-pyrrolidinyloxy-3'-pyridyle utilises comme regulateurs de la transmission synaptique chimique
DE10117686A1 (de) * 2001-04-09 2002-10-24 Celanese Ventures Gmbh Protonenleitende Membran und deren Verwendung
JP2005514362A (ja) * 2001-11-19 2005-05-19 イーラン ファーマスーティカルズ、インコーポレイテッド 3,4二置換、3,5二置換、及び3,4,5置換ピペリジン及びピペラジン
EP1638939A2 (fr) * 2003-06-24 2006-03-29 Neurosearch A/S Derives de noyaux aza et utilisation de ceux-ci comme inhibiteurs de la recapture des neurotransmetteurs monoaminergiques
CA2529790A1 (fr) * 2003-06-27 2005-01-27 Banyu Pharmaceutical Co., Ltd. Derive heterocyclique sature azote d'heteroaryloxy
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070232659A1 (en) * 2004-06-18 2007-10-04 Dan Peters Novel Alkyl Substituted Piperidine Derivatives as Monoamine Neurotransmitter Re-Uptake Inhibitors
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
ES2521494T3 (es) 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
WO2016123406A1 (fr) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Procédés et systèmes d'administration de médicament
JP6654960B2 (ja) * 2016-01-15 2020-02-26 日本曹達株式会社 ルテニウム錯体の製造方法
WO2018129304A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
CA3101966A1 (fr) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Procedes et systemes d'administration de medicament
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR829845A (fr) 1936-12-04 1938-07-07 Delle Atel Const Electr Coupe-circuit à basse tension à élément fusible rechargeable
FR2306697A1 (fr) * 1975-04-10 1976-11-05 Sogeras Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
US4379161A (en) * 1979-06-07 1983-04-05 Michel Thominet Novel substituted heterocyclic phenoxyamines, the method of preparation thereof and the use thereof as local anaesthetics
DE3227741A1 (de) * 1982-07-24 1984-01-26 Hoechst Ag, 6230 Frankfurt 1-phenyl-isochinolinderivate und verfahren zu ihrer herstellung
US4592866A (en) * 1982-09-30 1986-06-03 A. H. Robins Company, Inc. Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4667031A (en) * 1985-10-15 1987-05-19 Ethyl Corporation Process for preparing oxazepinones
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine
FR2640266B2 (fr) 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
DE4208254A1 (de) 1992-03-14 1993-09-16 Hoechst Ag Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
GB2295387A (en) * 1994-11-23 1996-05-29 Glaxo Inc Quinazoline antagonists of alpha 1c adrenergic receptors
IL118279A (en) * 1995-06-07 2006-10-05 Abbott Lab Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
EP0880501A1 (fr) * 1996-02-02 1998-12-02 Zeneca Limited Composes heterocycliques utiles en tant qu'agents pharmaceutiques
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
EP0863136B1 (fr) 1997-02-25 2003-09-24 Akzo Nobel N.V. Dérivés d'azétidine et de pyrrolidine
CA2341989A1 (fr) 1998-08-25 2000-03-02 Ortho-Mcneil Pharmaceutical, Inc. Pyridyl ethers et thioethers tenant lieu de ligands pour le recepteur de l'acetycholine nicotinique, et application therapeutique
DE19904261A1 (de) 1999-02-03 2000-08-10 Basf Ag Verfahren zur Herstellung von Dimethylsulfit
RU2145680C1 (ru) 1999-06-28 2000-02-20 Открытое акционерное общество "Магистральные нефтепроводы Центральной Сибири" Пеногенератор (варианты)
GB0203968D0 (en) 2002-02-19 2002-04-03 Gavon Res & Dev Ltd Mixer
JP2003297848A (ja) 2002-04-01 2003-10-17 Matsushita Electric Ind Co Ltd 半導体装置の製造方法

Also Published As

Publication number Publication date
EP1034174B1 (fr) 2003-08-13
US20040242558A1 (en) 2004-12-02
AU1022499A (en) 1999-05-31
CA2306477A1 (fr) 1999-05-20
DE69817214T2 (de) 2004-06-09
CN1173972C (zh) 2004-11-03
US20070161614A1 (en) 2007-07-12
HK1032234A1 (en) 2001-07-13
EP1357121A1 (fr) 2003-10-29
ATE247104T1 (de) 2003-08-15
EP1034174A1 (fr) 2000-09-13
US6756386B1 (en) 2004-06-29
DE69817214D1 (de) 2003-09-18
JP2001522846A (ja) 2001-11-20
WO1999024422A1 (fr) 1999-05-20
AU747419B2 (en) 2002-05-16
US7202237B2 (en) 2007-04-10
CN1278258A (zh) 2000-12-27
NZ503626A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
DK0984966T3 (da) 9-azabicyclo[3.3.1]non-2-en derivater, som er cholinerge ligander på nikotin-ACh receptorer
DE69817214D1 (de) Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren
CA2289574A1 (fr) Derives de 8-azabicyclo[3.2.1]oct-2-ene et -octane utilises comme ligands cholinergiques de recepteurs nicotiniques de l'ach
NO20060219L (no) Forbindelser
ATE254618T1 (de) Spiro chinuclidin-derivate, ihre herstellung und verwendung
ES2195933T3 (es) Nuevos derivados de flavonas, xantonas y cumarinas.
DE68906183D1 (de) 2'-desoxy-5-fluoruridinderivate.
FI844333L (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DE69839753D1 (de) 2-(Arylphenyl)amino-imidazolin-Derivate
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
LV12824B (lv) Fibrinogēnu receptoru antagonistu iegūšanas paņēmiens
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ES2090948T3 (es) Derivados de carbinol terciario 2-sustituidos de 1,5-iminoazucares como compuestos antivirales.
ATE204868T1 (de) 2-aryl-3-aminoaryloxynaphthylverbindungen, zwischenverbindungen, zusammensetzungen und verfahren
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
DE69911176D1 (de) Spiropiperidin-derivate
DE69810107D1 (de) Azacyclooktan- und heptan-derivate, ihre herstellung und ihre therapeutische verwendung
EP0407594A4 (en) Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients
ES8301480A1 (es) Un procedimiento para la produccion de derivados de 11-piperazinil-5h--pirrolo 1,2-b, 1,2,5 benzotriazepina.
DE69000806D1 (de) Indol-derivate.
ATE71367T1 (de) Verfahren zur herstellung von indolinen.
MX9202183A (es) Ftalidas substituidas, ftalidas heterociclicas y sus derivados, proceso para su preparacion y composiciones que contienen las mismas.
YU38498A (sh) Derivati 2-(arilfenil)amino-imidazolina